Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Cognetti

Showing results (21-30 of 275) with videos related to

Pageof 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2006
Does CTLA4 influence the suppressive effect of CD25+CD4+ regulatory T cells?Gianluigi Ferretti, Alessandra Felici, Maria Simona Pino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2008
Bevacizumab: one treatment for all the seasons?Alain J Gelibter, Susanna Di Segni, Massimo Zeuli, et al.
Expert Review of Anticancer Therapy|December 21, 2012
Sequential therapy in metastatic clear cell renal carcinoma: TKI-TKI vs TKI-mTORAlessandra Felici, Emilio Bria, Giampaolo Tortora, et al.
Journal of the National Cancer Institute|January 18, 2007
Re: Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysisEmilio Bria, Paolo Carlini, Francesco Cognetti, et al.
Current Opinion in Obstetrics & Gynecology|January 16, 2007
HER2/neu role in breast cancer: from a prognostic foe to a predictive friendGianluigi Ferretti, Alessandra Felici, Paola Papaldo, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 10, 2019
RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectivesMarco Infante, Alessandra Fabi, Francesco Cognetti, et al.
Anticancer Research|January 12, 2007
Severe skin reaction in a patient with gastrointestinal stromal tumor treated with imatinib mesylateVirginia Ferraresi, Caterina Catricalà, Mariangela Ciccarese, et al.
Bone|May 26, 2007
Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasisGianluigi Ferretti, Alessandra Fabi, Paolo Carlini, et al.
Anticancer Research|May 29, 2008
Unexpected clinical outcome in a patient with liver and brain metastasis from melanomaCarmen Nuzzo, Massimo Zeuli, Virginia Ferraresi, et al.
The Oncologist|January 1, 2008
Clinical utility of continuing trastuzumab beyond brain progression in HER-2 positive metastatic breast cancerGiulio Metro, Isabella Sperduti, Michelangelo Russillo, et al.
Pageof 28

Showing results (21-30 of 275) with videos related to

Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2006
Does CTLA4 influence the suppressive effect of CD25+CD4+ regulatory T cells?Gianluigi Ferretti, Alessandra Felici, Maria Simona Pino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2008
Bevacizumab: one treatment for all the seasons?Alain J Gelibter, Susanna Di Segni, Massimo Zeuli, et al.
Expert Review of Anticancer Therapy|December 21, 2012
Sequential therapy in metastatic clear cell renal carcinoma: TKI-TKI vs TKI-mTORAlessandra Felici, Emilio Bria, Giampaolo Tortora, et al.
Journal of the National Cancer Institute|January 18, 2007
Re: Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysisEmilio Bria, Paolo Carlini, Francesco Cognetti, et al.
Current Opinion in Obstetrics & Gynecology|January 16, 2007
HER2/neu role in breast cancer: from a prognostic foe to a predictive friendGianluigi Ferretti, Alessandra Felici, Paola Papaldo, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 10, 2019
RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectivesMarco Infante, Alessandra Fabi, Francesco Cognetti, et al.
Anticancer Research|January 12, 2007
Severe skin reaction in a patient with gastrointestinal stromal tumor treated with imatinib mesylateVirginia Ferraresi, Caterina Catricalà, Mariangela Ciccarese, et al.
Bone|May 26, 2007
Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasisGianluigi Ferretti, Alessandra Fabi, Paolo Carlini, et al.
Anticancer Research|May 29, 2008
Unexpected clinical outcome in a patient with liver and brain metastasis from melanomaCarmen Nuzzo, Massimo Zeuli, Virginia Ferraresi, et al.
The Oncologist|January 1, 2008
Clinical utility of continuing trastuzumab beyond brain progression in HER-2 positive metastatic breast cancerGiulio Metro, Isabella Sperduti, Michelangelo Russillo, et al.
Pageof 28